Once again on rapamycin-induced insulin resistance and longevity: Despite of or owing to

80Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

Abstract

Calorie restriction (CR), which deactivates the nutrient-sensing mTOR pathway, slows down aging and prevents age-related diseases such as type II diabetes. Compared with CR, rapamycin more efficiently inhibits mTOR. Noteworthy, severe CR and starvation cause a reversible condition known as "starvation diabetes. " As was already discussed, chronic administration of rapamycin can cause a similar condition in some animal models. A recent paper published in Science reported that chronic treatment with rapamycin causes a diabetes-like condition in mice by indirectly inhibiting mTOR complex 2. Here I introduce the notion of benevolent diabetes and discuss whether starvation-like effects of chronic high dose treatment with rapamycin are an obstacle for its use as an anti-aging drug. © Blagosklonny.

Cite

CITATION STYLE

APA

Blagosklonny, M. V. (2012). Once again on rapamycin-induced insulin resistance and longevity: Despite of or owing to. Aging, 4(5), 350–358. https://doi.org/10.18632/aging.100461

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free